Biogen Idec hires gene therapy SVP

Biogen Idec Inc. (NASDAQ:BIIB) moved a step further into the gene editing space by hiring Olivier Danos as SVP of gene therapy, a newly created position.

The company said it is "exploring" gene editing technologies and that it brought Danos on board to help "build out" its capabilities. ...